Deutsche Bank AG Invests $1 Million in Grail, Inc. (NASDAQ:GRAL)

Deutsche Bank AG acquired a new position in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 56,062 shares of the company's stock, valued at approximately $1,001,000. Deutsche Bank AG owned about 0.17% of Grail at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the stock. Crcm LP acquired a new stake in Grail in the fourth quarter valued at approximately $65,061,000. Primecap Management Co. CA purchased a new position in shares of Grail during the fourth quarter valued at approximately $37,118,000. Baker BROS. Advisors LP purchased a new position in shares of Grail during the fourth quarter valued at approximately $29,098,000. Vanguard Group Inc. bought a new stake in Grail during the fourth quarter worth $25,902,000. Finally, AQR Capital Management LLC bought a new stake in Grail during the fourth quarter worth $14,828,000.

Analysts Set New Price Targets

A number of brokerages recently commented on GRAL. Morgan Stanley lifted their price target on Grail from $16.00 to $20.00 and gave the stock an "equal weight" rating in a report on Tuesday, March 18th. Canaccord Genuity Group lifted their price target on Grail from $32.00 to $43.00 and gave the company a "buy" rating in a research report on Wednesday, May 14th.

Grail Stock Performance

Grail stock traded down $3.40 during midday trading on Friday, hitting $37.70. 1,588,983 shares of the company's stock were exchanged, compared to its average volume of 1,256,076. Grail, Inc. has a 52-week low of $12.33 and a 52-week high of $63.99. The stock has a 50-day moving average price of $32.06 and a two-hundred day moving average price of $28.40. The company has a market cap of $1.36 billion and a P/E ratio of -0.62.

Grail (NASDAQ:GRAL - Get Free Report) last posted its quarterly earnings data on Tuesday, May 13th. The company reported ($3.10) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($4.03) by $0.93. The firm had revenue of $31.84 million during the quarter, compared to analysts' expectations of $35.80 million. As a group, sell-side analysts expect that Grail, Inc. will post -15.15 earnings per share for the current year.

Insider Transactions at Grail

In other news, CEO Robert P. Ragusa sold 7,625 shares of the business's stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $31.21, for a total value of $237,976.25. Following the completion of the sale, the chief executive officer now owns 828,662 shares of the company's stock, valued at approximately $25,862,541.02. The trade was a 0.91% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, President Joshua J. Ofman sold 2,109 shares of the company's stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $65,800.80. Following the transaction, the president now directly owns 559,673 shares of the company's stock, valued at $17,461,797.60. The trade was a 0.38% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 194,948 shares of company stock worth $6,583,130. 1.85% of the stock is currently owned by corporate insiders.

About Grail

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.